Per Westermark
Impact in
- Physiology top 0.05%
- Alzheimer's disease research and treatments
- Nephrology top 0.2%
- Parathyroid Disorders and Treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 213
- Prion Diseases and Protein Misfolding 27
- Physiology 128
- Alzheimer's disease research and treatments 119
- Co-authors
- Gunilla T. Westermark (85 shared papers)Knut Sletten (59 shared papers)Erik Wilander (16 shared papers)Kenneth H. Johnson (38 shared papers)Timothy D. O’Brien (28 shared papers)Giampaolo Merlini (12 shared papers)Gibbons G. Cornwell (13 shared papers)Ulla Engström (19 shared papers)
- Journals
- Amyloid (49 papers)Biochemical and Biophysical Research Communications (21 papers)Scandinavian Journal of Immunology (15 papers)Diabetologia (13 papers)Proceedings of the National Academy of Sciences (11 papers)
- Partner nations
- SwedenUnited StatesNorway
In The Last Decade
Per Westermark
363 papers receiving 22.5k citations
Per Westermark's Hit Papers
Peers
Comparison fields: 5 of 158
- Physiology 8.8k
- Nephrology 1.6k
- Molecular Biology 15.2k
- Cell Biology 2.7k
- Endocrinology, Diabetes and Metabolism 2.3k
Countries citing papers authored by Per Westermark
This map shows the geographic impact of Per Westermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Westermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Westermark more than expected).
Fields of papers citing papers by Per Westermark
This network shows the impact of papers produced by Per Westermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Westermark. The network helps show where Per Westermark may publish in the future.
Co-authors
The 25 scholars most cited alongside Per Westermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 373 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus Hit paper breakdown → | 2011 | 818 |
| 2 | Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Hit paper breakdown → | 1987 | 817 |
| 3 | Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Hit paper breakdown → | 1990 | 688 |
| 4 | Fibril in senile systemic amyloidosis is derived from normal transthyretin. Hit paper breakdown → | 1990 | 550 |
| 5 | 2004 | 459 | |
| 6 | Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines Hit paper breakdown → | 2016 | 442 |
| 7 | 1986 | 416 | |
| 8 | Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Hit paper breakdown → | 2018 | 401 |
| 9 | 2004 | 351 | |
| 10 | 1983 | 344 | |
| 11 | 1989 | 307 | |
| 12 | Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee Hit paper breakdown → | 2020 | 280 |
| 13 | 2011 | 261 | |
| 14 | 1988 | 248 | |
| 15 | 2007 | 248 | |
| 16 | 2005 | 248 | |
| 17 | 2005 | 246 | |
| 18 | 2010 | 246 | |
| 19 | 1999 | 241 | |
| 20 | 2015 | 240 |
About Per Westermark
Per Westermark is a scholar working on Molecular Biology, Physiology, Surgery, Genetics and Endocrinology, Diabetes and Metabolism, having authored 373 papers that have together received 23.2k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (213 papers), Alzheimer's disease research and treatments (119 papers), Pancreatic function and diabetes (71 papers), Dermatological and Skeletal Disorders (37 papers), Diabetes Treatment and Management (34 papers), Parathyroid Disorders and Treatments (29 papers), Prion Diseases and Protein Misfolding (27 papers) and Trace Elements in Health (25 papers). The work is most often cited by research in Physiology (8.8k citations), Nephrology (1.6k citations), Molecular Biology (15.2k citations), Cell Biology (2.7k citations) and Endocrinology, Diabetes and Metabolism (2.3k citations). Per Westermark has collaborated with scholars based in Sweden, United States and Norway. Frequent co-authors include Gunilla T. Westermark, Knut Sletten, Erik Wilander, Kenneth H. Johnson, Timothy D. O’Brien, Giampaolo Merlini, Gibbons G. Cornwell, Ulla Engström, Christer Wernstedt and Arne Andersson. Their work appears in journals such as Amyloid, Biochemical and Biophysical Research Communications, Scandinavian Journal of Immunology, Diabetologia and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.